Hyper-homocysteinemia Inducing Hyperuricemia: What are the Mechanisms?
Journal of Rheumatic Diseases
; : 127-130, 2017.
Article
de En
| WPRIM
| ID: wpr-116476
Bibliothèque responsable:
WPRO
ABSTRACT
Hyperuricemia is related to metabolic syndrome, and is defined as an over-production or under-excretion of uric acid (UA), with increased UA serum concentration. Among other causes, Hyper-homocysteinemia (H-Hcy) can be responsible for hyperuricemia. The mechanisms underlying the association between these two conditions are unclear, but increased UA serum levels can be a consequence of renovascular atherosclerosis, with reduced UA excretion. An alternative hypothesis is the over-production of UA from adenosine (originating from S-adenosyl-homocysteine). Genetic polymorphism (C677T) of methylenetetrahydrofolate reductase (MTHFR) may contribute. A possible mechanism is purines biosyinthesis originating from this gene variant. However, the results obtained from several studies and meta-analyses of the relationship between H-Hcy and hyperuricemia are ambivalent, and broader research is needed.
Mots clés
Texte intégral:
1
Indice:
WPRIM
Sujet Principal:
Polymorphisme génétique
/
Purines
/
Acide urique
/
Adénosine
/
Hyperuricémie
/
Methylenetetrahydrofolate reductase (NADPH2)
/
Athérosclérose
/
Homocystéine
langue:
En
Texte intégral:
Journal of Rheumatic Diseases
Année:
2017
Type:
Article